🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lou‐Anne Acevedo‐Moreno

Cleveland Clinic

ORCID: 0000-0001-8793-2254

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles”.

Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles

Scientific Reports(2020)10.1038/s41598-020-75881-1

N/A

0.470DataRank · unranked

22 citations

Adam Lauko, Gustavo Roversi, Emily Serbinowski, Lou‐Anne Acevedo‐Moreno, Christopher Lanigan +11 more

Salivary metabolites are promising non‐invasive biomarkers of hepatocellular carcinoma and chronic liver disease

Liver Cancer International(2021)10.1002/lci2.25

N/A

0DataRank · unranked

32 citations

Alejandro I. Rodarte, Shirin Siddiqi, Amika Moro, Lou‐Anne Acevedo‐Moreno, J. Mark Brown +4 more

Salivary miRNAs as non-invasive biomarkers of hepatocellular carcinoma: a pilot study

PeerJ(2022)10.7717/peerj.12715

N/A

0DataRank · unranked

15 citations

Galen Miller‐Atkins, Amika Moro, Alejandro I. Rodarte, Shirin Siddiqi, Lou‐Anne Acevedo‐Moreno +5 more